These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21680653)

  • 1. Fully automated atlas-based MR imaging volumetry in Huntington disease, compared with manual volumetry.
    Kassubek J; Pinkhardt EH; Dietmaier A; Ludolph AC; Landwehrmeyer GB; Huppertz HJ
    AJNR Am J Neuroradiol; 2011 Aug; 32(7):1328-32. PubMed ID: 21680653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External evaluation of a deep learning-based approach for automated brain volumetry in patients with huntington's disease.
    Haase R; Lehnen NC; Schmeel FC; Deike K; Rüber T; Radbruch A; Paech D
    Sci Rep; 2024 Apr; 14(1):9243. PubMed ID: 38649395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automated quantification of caudate atrophy by local registration of serial MRI: evaluation and application in Huntington's disease.
    Hobbs NZ; Henley SM; Wild EJ; Leung KK; Frost C; Barker RA; Scahill RI; Barnes J; Tabrizi SJ; Fox NC
    Neuroimage; 2009 Oct; 47(4):1659-65. PubMed ID: 19523522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined cerebral atrophy score in Huntington's disease based on atlas-based MRI volumetry: Sample size calculations for clinical trials.
    Müller HP; Huppertz HJ; Dreyhaupt J; Ludolph AC; Tabrizi SJ; Roos RAC; Durr A; Landwehrmeyer GB; Kassubek J
    Parkinsonism Relat Disord; 2019 Jun; 63():179-184. PubMed ID: 30846243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Onset and progression of pathologic atrophy in Huntington disease: a longitudinal MR imaging study.
    Hobbs NZ; Barnes J; Frost C; Henley SM; Wild EJ; Macdonald K; Barker RA; Scahill RI; Fox NC; Tabrizi SJ
    AJNR Am J Neuroradiol; 2010 Jun; 31(6):1036-41. PubMed ID: 20150305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Putamen volume reduction on magnetic resonance imaging exceeds caudate changes in mild Huntington's disease.
    Harris GJ; Pearlson GD; Peyser CE; Aylward EH; Roberts J; Barta PE; Chase GA; Folstein SE
    Ann Neurol; 1992 Jan; 31(1):69-75. PubMed ID: 1531910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative 7T phase imaging in premanifest Huntington disease.
    Apple AC; Possin KL; Satris G; Johnson E; Lupo JM; Jakary A; Wong K; Kelley DA; Kang GA; Sha SJ; Kramer JH; Geschwind MD; Nelson SJ; Hess CP
    AJNR Am J Neuroradiol; 2014 Sep; 35(9):1707-13. PubMed ID: 24742810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-Sectional Area Analysis of the Head of the Caudate Nucleus in Huntington's Disease.
    Furukawa F; Ishikawa K; Yokota T; Sanjo N
    Eur Neurol; 2019; 81(1-2):13-18. PubMed ID: 31013498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. White matter integrity in premanifest and early Huntington's disease is related to caudate loss and disease progression.
    Novak MJ; Seunarine KK; Gibbard CR; Hobbs NZ; Scahill RI; Clark CA; Tabrizi SJ
    Cortex; 2014 Mar; 52():98-112. PubMed ID: 24405816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion-weighted versus volumetric imaging of the striatum in early symptomatic Huntington disease.
    Vandenberghe W; Demaerel P; Dom R; Maes F
    J Neurol; 2009 Jan; 256(1):109-14. PubMed ID: 19267169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodal imaging biomarkers in premanifest and early Huntington's disease: 30-month IMAGE-HD data.
    D JF; Stout JC; Poudel G; Churchyard A; Chua P; Egan GF; Georgiou-Karistianis N
    Br J Psychiatry; 2016 Jun; 208(6):571-8. PubMed ID: 26678864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Onset and rate of striatal atrophy in preclinical Huntington disease.
    Aylward EH; Sparks BF; Field KM; Yallapragada V; Shpritz BD; Rosenblatt A; Brandt J; Gourley LM; Liang K; Zhou H; Margolis RL; Ross CA
    Neurology; 2004 Jul; 63(1):66-72. PubMed ID: 15249612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface-based morphometry reveals caudate subnuclear structural damage in patients with premotor Huntington disease.
    Kim H; Kim JH; Possin KL; Winer J; Geschwind MD; Xu D; Hess CP
    Brain Imaging Behav; 2017 Oct; 11(5):1365-1372. PubMed ID: 27730480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Segmentation and volumetric analysis of the caudate nucleus in Alzheimer's disease.
    Jiji S; Smitha KA; Gupta AK; Pillai VP; Jayasree RS
    Eur J Radiol; 2013 Sep; 82(9):1525-30. PubMed ID: 23664648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validating Automated Segmentation Tools in the Assessment of Caudate Atrophy in Huntington's Disease.
    Mansoor NM; Vanniyasingam T; Malone I; Hobbs NZ; Rees E; Durr A; Roos RAC; Landwehrmeyer B; Tabrizi SJ; Johnson EB; Scahill RI
    Front Neurol; 2021; 12():616272. PubMed ID: 33935934
    [No Abstract]   [Full Text] [Related]  

  • 16. Striatal morphology correlates with frontostriatal electrophysiological motor processing in Huntington's disease: an IMAGE-HD study.
    Turner LM; Jakabek D; Wilkes FA; Croft RJ; Churchyard A; Walterfang M; Velakoulis D; Looi JC; Georgiou-Karistianis N; Apthorp D
    Brain Behav; 2016 Dec; 6(12):e00511. PubMed ID: 28031992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shape analysis of subcortical nuclei in Huntington's disease, global versus local atrophy--results from the TRACK-HD study.
    van den Bogaard SJ; Dumas EM; Ferrarini L; Milles J; van Buchem MA; van der Grond J; Roos RA
    J Neurol Sci; 2011 Aug; 307(1-2):60-8. PubMed ID: 21624624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Finding of increased caudate nucleus in patients with Alzheimer's disease.
    Persson K; Bohbot VD; Bogdanovic N; Selbaek G; Braekhus A; Engedal K
    Acta Neurol Scand; 2018 Feb; 137(2):224-232. PubMed ID: 28741672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caudate nucleus atrophy in Huntington's disease and its relationship with clinical and genetic parameters.
    Roth J; Klempìi J; Jech R; Zidovská J; Uhrová T; Doubek P; Ulmanová O; Brozová H; Volfová M; Serranová T; Ruzicka E
    Funct Neurol; 2005; 20(3):127-30. PubMed ID: 16324236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Huntington disease: volumetric, diffusion-weighted, and magnetization transfer MR imaging of brain.
    Mascalchi M; Lolli F; Della Nave R; Tessa C; Petralli R; Gavazzi C; Politi LS; Macucci M; Filippi M; Piacentini S
    Radiology; 2004 Sep; 232(3):867-73. PubMed ID: 15215553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.